Crowdfunding is a significant and meaningful opportunity for emerging Life Science companies and individual investors, alike. America’s greatest asset has always been its people. The US was built upon microfunding. People doing business with people is the premise that resides at the very core of Capitalist ideals. This legislation beacons a return to civics and to personal enterprise. To remain at the leading edge of both innovation and prosperity Americans have to take control of our individual and collective destiny. This legislation presents an opportunity to regain the trust and camaraderie among citizens and corporations in restoring those capitalist ideals. With social media as the driver, communities and industries can invest in their collective interest.
The Life Science community is especially well suited to answer this call. Those endeavored in emerging Life Sciences are, on the whole, inherently well educated, well intentioned, highly professional and highly credible. These trust factors align emerging Life Science companies with the inspiration of an investing public. Nothing is more meaningful to an investor or the founder of a Life Science company than the opportunity to ‘Do Well by Doing Good’. Sentimentally, Crowdfunding presents the entrepreneur with an incredibly meaningful socioeconomic mandate. It is one thing to grow shareholder value on behalf of some perceivably ruthless institutional investor. It is an especially meaningful mandate to be entrusted to steward the hard-earned dollars of a cancer victim. There is no bigger motivation than to look an individual who is in peril in his eye with assurance, to pledge responsibility for his hopes and aspirations, and to consecrate his dying wish with a handshake.
The reward for success and the consequence for failure are both deeply personal and carry tremendous weight. A perfectly fitting inspiration from which to incent innovation. Only in Life Science!